Compare Cronos Group Inc (CRON) vs Relay Therapeutics Inc. Common Stock (RLAY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cronos Group Inc vs Relay Therapeutics Inc. Common Stock — how do they compare? Cronos Group Inc trades at $3.23 (market cap $1.18B), while Relay Therapeutics Inc. Common Stock trades at $17.46 (market cap $3.82B). The key difference: Relay Therapeutics Inc. Common Stock is far larger — about 3.2× Cronos Group Inc's market cap, and Cronos Group Inc is more actively traded (968,037 versus 4,332,079). Which is the better fit depends on your goals — on Pluang, investors hold Cronos Group Inc for 22 Days and Relay Therapeutics Inc. Common Stock for 0 Days on average.
| CRON | RLAY | |
|---|---|---|
Market Cap | $1.18B | $3.82B |
Volume | 968,037 | 4,332,079 |
Sector | Health | Health |
52-Week High | $3.55 | $20.75 |
52-Week Low | $2.30 | $6.03 |
Typical Hold Time | 22 Days | 0 Days |
Enterprise Value | $387.62M | $2.93B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CRON trades at $3.24, down 1.37% on the day, with a bearish technical signal and neutral oscillators. The company reported a net loss of $9.45M in 2025 despite revenue growth to $146.59M, but recent quarters show earnings beats. Analyst sentiment is mixed with 20% buy, 60% hold, and 20% sell ratings. Recent news highlights investor day events and international expansion efforts.
The outlook is cautious; profitability improvements and cash flow generation are key catalysts, but high valuation multiples and negative net cash flow pose risks. Regulatory developments in cannabis markets and execution on growth targets will be critical for stock performance.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cronos Group Inc
Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.
Read more on CRON →About Relay Therapeutics Inc. Common Stock
Relay Therapeutics develops precision medicines for oncology and genetic diseases. Its drug discovery platform studies how protein motion affects drug targets to guide small-molecule medicine design.
Read more on RLAY →
